financetom
Business
financetom
/
Business
/
Sonder to Liquidate US Operations After Marriott Licensing Deal Collapse
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sonder to Liquidate US Operations After Marriott Licensing Deal Collapse
Nov 10, 2025 10:10 AM

12:48 PM EST, 11/10/2025 (MT Newswires) -- Sonder Holdings ( SOND ) plans to wind down operations immediately and file for Chapter 7 liquidation of its US business following the termination of its licensing agreement with Marriott International ( MAR ) .

"Our integration with Marriott International ( MAR ) was substantially delayed due to unexpected challenges in aligning our technology frameworks, resulting in significant, unanticipated integration costs, as well as a sharp decline in revenue," Sonder ( SOND ) said Monday in a statement.

Sonder ( SOND ) "ultimately was unable to execute a viable going concern transaction for its business and operations or obtain additional liquidity," according to the statement.

Sonder ( SOND ) shares fell 62% in recent Monday trading, and Marriott ( MAR ) declined 0.3%.

Price: 0.19, Change: -0.32, Percent Change: -61.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbus faces new output pressure amid parts shortages, sources say
Airbus faces new output pressure amid parts shortages, sources say
May 31, 2024
PARIS, May 31 (Reuters) - Airbus is facing new pressure on its near-term production ramp-up for passenger jets due to parts and labour shortages, industry sources said on Thursday. It was not immediately clear whether the slowdown would put at risk delivery targets for 2024 since deliveries lag output decisions by several months, but the sources said assembly of several...
Update: Marvell Technology's Shares Decline Pre-Bell After Fiscal Q1 Adjusted Earnings, Revenue Decline
Update: Marvell Technology's Shares Decline Pre-Bell After Fiscal Q1 Adjusted Earnings, Revenue Decline
May 31, 2024
05:22 AM EDT, 05/31/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Marvell Technology's ( MRVL ) shares were down more than 4% in premarket activity Friday after the company reported overnight a decline in fiscal Q1 earnings and sales. The company reported fiscal Q1 adjusted earnings late Thursday of $0.24 per diluted...
Update: Dell Technologies Fiscal Q1 Non-GAAP Earnings Fall More Than Forecast While Sales Increase; Shares Sink Premarket
Update: Dell Technologies Fiscal Q1 Non-GAAP Earnings Fall More Than Forecast While Sales Increase; Shares Sink Premarket
May 31, 2024
05:20 AM EDT, 05/31/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Dell Technologies ( DELL ) shares were down 14% in premarket activity Friday after the company reported overnight a steeper-than-anticipated decline in fiscal Q1 earnings. The company reported fiscal Q1 non-GAAP earnings late Thursday of $1.27 per diluted share, down from...
Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US
Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US
May 31, 2024
05:12 AM EDT, 05/31/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said late Thursday it is now allowed to commercialize Ponvory, or ponesimod, in the US. The company said the move follows the transfer of ownership of the US new drug application and investigational new drug applications of ponesimod to the company from a Johnson & Johnson company. Ponvory...
Copyright 2023-2026 - www.financetom.com All Rights Reserved